Gapping up
In reaction to strong earnings/guidance: BBEP +5%, JOB +2.4%, MZOR +0.5%
Select Air carrier related names showing strength after RYAAY traffic results: HA +4.4%, JBLU +1.3%, DAL +0.9%
Select biotech/pharma names trading higher: ETRM +3.4%, MNKD +2.5%, KITE +2.1%, ACHN +0.9%, SPPI +0.7%
Other news: CNAT +39.9% (will report top-line results from three clinical trials in subjects with varying degrees of organ impairment on Thursday afternoon), CEMP +14.5% (reports positive topline Phase 3 clinical results for oral Solithromycin), CNET +8.3% (announced that the Board of directors has appointed Mr. Qiu Chang as an independent director), RDHL +5.4% (updates business outlook and anticipated key milestones for 2015), ESLT +5.1% (announced 2 new contract wins), PLX +4.8% (announces new strategy for accelerated growth), ISIS +3.9% (entered into a global collaboration with Janssen Biotech (JNJ unit) to discover and develop antisense drugs to treat autoimmune disorders of the gastrointestinal tract), PLUG +3.7% (executed a multi-year contract with SouthernLINC Wireless), CGEN +3.3% (positive initial experimental results for the first two of five in silico predicted targets for antibody drug conjugate cancer therapy disclosed in late 2013), CTC +2.9% (receives delisting notice from NYSE), LOGI +2.9% (presenting at CES tomorrow), ADXS +2.1% (submits investigational new drug application to FDA for ADXS-HER2), RYAAY +1.9% (reported Dec traffic), ADS +1.3% (approves $600 mln stock repurchase plan), SGMS +1.2% (Investor group files amended SC13D related to trading plan), AAL +1% (reached an agreement in principle regarding a tentative joint collective bargaining agreement with the Allied Pilots Association, which represents American's more than 14,000 pilots), .
Analyst comments: VUZI +10% (named top pick at Chardan), LOCO +4.1% (upgraded to Outperform from Neutral at Robert W. Baird), RDWR +2.2% (upgraded to Outperform at Oppenheimer), BSX +1.5% (upgraded to Overweight from Neutral at JP Morgan), CTSH +1.3% (upgraded to Buy from Neutral at Goldman), GPS +1.2% (upgraded to Buy from Hold at Jefferies, also named best idea for 2015), CCL +1.2% (upgraded to Outperform from Mkt Perform at Raymond James), LQ +1.1% upgraded to Buy from Neutral at Goldman), MRK +1% (upgraded to Outperform from Mkt Perform at Bernstein), FFIV +0.9% (upgraded to Outperform at Oppenheimer
In reaction to strong earnings/guidance: BBEP +5%, JOB +2.4%, MZOR +0.5%
Select Air carrier related names showing strength after RYAAY traffic results: HA +4.4%, JBLU +1.3%, DAL +0.9%
Select biotech/pharma names trading higher: ETRM +3.4%, MNKD +2.5%, KITE +2.1%, ACHN +0.9%, SPPI +0.7%
Other news: CNAT +39.9% (will report top-line results from three clinical trials in subjects with varying degrees of organ impairment on Thursday afternoon), CEMP +14.5% (reports positive topline Phase 3 clinical results for oral Solithromycin), CNET +8.3% (announced that the Board of directors has appointed Mr. Qiu Chang as an independent director), RDHL +5.4% (updates business outlook and anticipated key milestones for 2015), ESLT +5.1% (announced 2 new contract wins), PLX +4.8% (announces new strategy for accelerated growth), ISIS +3.9% (entered into a global collaboration with Janssen Biotech (JNJ unit) to discover and develop antisense drugs to treat autoimmune disorders of the gastrointestinal tract), PLUG +3.7% (executed a multi-year contract with SouthernLINC Wireless), CGEN +3.3% (positive initial experimental results for the first two of five in silico predicted targets for antibody drug conjugate cancer therapy disclosed in late 2013), CTC +2.9% (receives delisting notice from NYSE), LOGI +2.9% (presenting at CES tomorrow), ADXS +2.1% (submits investigational new drug application to FDA for ADXS-HER2), RYAAY +1.9% (reported Dec traffic), ADS +1.3% (approves $600 mln stock repurchase plan), SGMS +1.2% (Investor group files amended SC13D related to trading plan), AAL +1% (reached an agreement in principle regarding a tentative joint collective bargaining agreement with the Allied Pilots Association, which represents American's more than 14,000 pilots), .
Analyst comments: VUZI +10% (named top pick at Chardan), LOCO +4.1% (upgraded to Outperform from Neutral at Robert W. Baird), RDWR +2.2% (upgraded to Outperform at Oppenheimer), BSX +1.5% (upgraded to Overweight from Neutral at JP Morgan), CTSH +1.3% (upgraded to Buy from Neutral at Goldman), GPS +1.2% (upgraded to Buy from Hold at Jefferies, also named best idea for 2015), CCL +1.2% (upgraded to Outperform from Mkt Perform at Raymond James), LQ +1.1% upgraded to Buy from Neutral at Goldman), MRK +1% (upgraded to Outperform from Mkt Perform at Bernstein), FFIV +0.9% (upgraded to Outperform at Oppenheimer